Skip to main content

Table 2 Clinical background and staining results of the diseased bladder

From: Expression of parathyroid hormone/parathyroid hormone-related peptide receptor 1 in normal and diseased bladder detrusor muscles: a clinico-pathological study

  Gender Age Maximal Bladder Capacity Intravesical Pressure at Maximal Capacity (cmH2O) Compliance (ml/cmH2O) DO VUR Leak Point Pressure (cmH2O) IHC-PTH1R
Maximal Capacity (ml) Percent capacity of age standard Detrusor Blood vessels
Myelomeningocele-1 M 14 60 17.1 40 1.5 - - Incontinent - -
Myelomeningocele-2 F 15 117 33.4 53 2.21 - + >60 - +
Myelomeningocele-3 M 20 250 71.4 24 10.4 - - 25 - -
Myelomeningocele-4 F 27 147 42.0 30 4.9 - + 22.5 - -
Myelomeningocele-5 F 29 212 60.6 23 9.22 + + 25 - -
Sacral agenesis-1 M 30 146 41.7 30 4.87 - + NA - +
Sacral agenesis-2 F 31 266 76.0 30 8.87 - + NA - -
Posterior urethral valve-1 M 8 109 43.6 47 2.32 - - >40 - +
Posterior urethral valve-2 M 10 147 49.0 40 3.68 - + >40 - +
Posterior urethral valve-3 M 11 5 1.5 107 0.05 + - NA - -
Hinman syndrome-1 M 8 118 47.2 30 3.93 + + >60 - +
Hinman syndrome-2 M 10 117 39.0 40 2.93 + - Incontinent - +
Hinman syndrome-3 M 18 303 86.6 10 30.3 + + NA - +
  1. DO, detrusor overactivity; VUR, vesicouteral reflux; IHC, immunohistochemistry.